Human papillomavirus vaccination and Pap testing profile in Manitoba, Canada
Abstract Background Females who receive the human papillomavirus (HPV) vaccine may believe they are protected from developing cervical cancer and no longer require screening. Concern has also been expressed that vaccinated females are those that would be screened regularly. This study assesses the P...
Gespeichert in:
| Veröffentlicht in: | Vaccine 2013-12, Vol.32 (1), p.33-38 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 38 |
|---|---|
| container_issue | 1 |
| container_start_page | 33 |
| container_title | Vaccine |
| container_volume | 32 |
| creator | Kliewer, Erich V Mahmud, Salaheddin M Demers, Alain A Lambert, Pascal |
| description | Abstract Background Females who receive the human papillomavirus (HPV) vaccine may believe they are protected from developing cervical cancer and no longer require screening. Concern has also been expressed that vaccinated females are those that would be screened regularly. This study assesses the Pap testing behavior of vaccinated and non-vaccinated females. Methods For this population-based retrospective cohort study, vaccination and screening registries were linked for 3540 vaccinated females aged 15 years and over and 9592 matched non-vaccinated females. Conditional logistic regression, the Kaplan–Meier method and Cox regression were used to examine the association between vaccination and Pap testing. Results Vaccinated females were more likely to have had a Pap test within the year prior to the index date than non-vaccinated females (15–19 years old: OR = 1.38, 95% CI 1.20–1.59; 20+ years old: OR = 2.34, 95% CI 1.98–2.76). In the three-year period after the index date, vaccinated females had a significantly higher cumulative probability of having a Pap test (83.3%) than non-vaccinated females (66.1%). Females who had a Pap test within three years prior to the index date were more likely to have a Pap test after the index date (vaccinated: HR = 5.03, 95% CI 4.65–5.45; non-vaccinated HR = 3.97, 95% CI 3.70–4.24). Being vaccinated had a significant effect on Pap testing (15–19 years old: HR = 1.54, 95% CI 1.39–1.69; 20+ years old: HR = 1.87, 95% CI 1.52–2.31). 80.1% of vaccinated females who had a Pap test prior to the index date also had one subsequent to it, compared to 70.1% for non-vaccinated females. 41.1% of females had not been vaccinated nor had a Pap test. Conclusion The majority of vaccinated females continue to participate in screening, and do so at a higher rate than non-vaccinated females. Renewed efforts need to be made to include the large proportion of non–vaccinated, non–screened females in vaccination and/or screening. |
| doi_str_mv | 10.1016/j.vaccine.2013.10.082 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1516753871</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X13014898</els_id><sourcerecordid>3396337651</sourcerecordid><originalsourceid>FETCH-LOGICAL-c535t-bcc4af34cae1902326f25cfd15eb622282d8adb85953d8534877b2fa91d34973</originalsourceid><addsrcrecordid>eNqFktGL1DAQxoMo3nr6J6gFEXywayZp2uRFkUU9YUXhTvAtTNP0yNqmNWkX7r83pasH93JPgeE333yTbwh5DnQLFMp3h-0RjXHebhkFnmpbKtkDsgFZ8ZwJkA_JhrKyyAugv87IkxgPlFLBQT0mZ6xgAFDRDdlfzD36bMTRdd3Q49GFOWarNE5u8Bn6JvuBYzbZODl_nY1haF1nM-ezb-jdNNT4NtuhxwafkkctdtE-O73n5Orzp6vdRb7__uXr7uM-N4KLKa-NKbDlhUELijLOypYJ0zYgbF0yxiRrJDa1FErwRgpeyKqqWYsKGl6oip-TN6tssvJnTrZ076KxXYfeDnPUIKCsBJcV3I8WVSWEkpQm9NUd9DDMwac9kqAAJUslltlipUwYYgy21WNwPYYbDVQvweiDPgWjl2CWcgom9b04qc91b5v_Xf-SSMDrE4DRYNcG9MbFW06mLMty4V6uXIuDxuuQmJ-XaZKgFCrFhUrEh5WwKYKjs0FH46w3tnHBmkk3g7vX7Ps7CqZz3iVbv-2Njbf_oiPTVF8ud7acGXAKhVSS_wUyv8o8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1551986957</pqid></control><display><type>article</type><title>Human papillomavirus vaccination and Pap testing profile in Manitoba, Canada</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>ProQuest Central UK/Ireland</source><creator>Kliewer, Erich V ; Mahmud, Salaheddin M ; Demers, Alain A ; Lambert, Pascal</creator><creatorcontrib>Kliewer, Erich V ; Mahmud, Salaheddin M ; Demers, Alain A ; Lambert, Pascal</creatorcontrib><description>Abstract Background Females who receive the human papillomavirus (HPV) vaccine may believe they are protected from developing cervical cancer and no longer require screening. Concern has also been expressed that vaccinated females are those that would be screened regularly. This study assesses the Pap testing behavior of vaccinated and non-vaccinated females. Methods For this population-based retrospective cohort study, vaccination and screening registries were linked for 3540 vaccinated females aged 15 years and over and 9592 matched non-vaccinated females. Conditional logistic regression, the Kaplan–Meier method and Cox regression were used to examine the association between vaccination and Pap testing. Results Vaccinated females were more likely to have had a Pap test within the year prior to the index date than non-vaccinated females (15–19 years old: OR = 1.38, 95% CI 1.20–1.59; 20+ years old: OR = 2.34, 95% CI 1.98–2.76). In the three-year period after the index date, vaccinated females had a significantly higher cumulative probability of having a Pap test (83.3%) than non-vaccinated females (66.1%). Females who had a Pap test within three years prior to the index date were more likely to have a Pap test after the index date (vaccinated: HR = 5.03, 95% CI 4.65–5.45; non-vaccinated HR = 3.97, 95% CI 3.70–4.24). Being vaccinated had a significant effect on Pap testing (15–19 years old: HR = 1.54, 95% CI 1.39–1.69; 20+ years old: HR = 1.87, 95% CI 1.52–2.31). 80.1% of vaccinated females who had a Pap test prior to the index date also had one subsequent to it, compared to 70.1% for non-vaccinated females. 41.1% of females had not been vaccinated nor had a Pap test. Conclusion The majority of vaccinated females continue to participate in screening, and do so at a higher rate than non-vaccinated females. Renewed efforts need to be made to include the large proportion of non–vaccinated, non–screened females in vaccination and/or screening.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2013.10.082</identifier><identifier>PMID: 24211170</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Allergy and Immunology ; Alphapapillomavirus - immunology ; Applied microbiology ; Biological and medical sciences ; Cervical cancer ; cohort studies ; Female ; females ; Fundamental and applied biological sciences. Psychology ; Human papillomavirus ; Human papillomavirus (HPV) ; Humans ; Immunization ; Manitoba - epidemiology ; Medical research ; Medical sciences ; Microbiology ; Middle Aged ; Miscellaneous ; Odds Ratio ; Pap test ; Papillomaviridae ; Papillomavirus Infections - diagnosis ; Papillomavirus Infections - epidemiology ; Papillomavirus Infections - prevention & control ; Papillomavirus Vaccines - immunology ; Population Surveillance ; probability ; Registries ; regression analysis ; Retrospective Studies ; Screening ; Tumors ; uterine cervical neoplasms ; Vaccination ; Vaccination - statistics & numerical data ; Vaccines ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) ; Vaginal Smears ; Virology ; Young Adult</subject><ispartof>Vaccine, 2013-12, Vol.32 (1), p.33-38</ispartof><rights>Elsevier Ltd</rights><rights>2013 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2013 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Dec 17, 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c535t-bcc4af34cae1902326f25cfd15eb622282d8adb85953d8534877b2fa91d34973</citedby><cites>FETCH-LOGICAL-c535t-bcc4af34cae1902326f25cfd15eb622282d8adb85953d8534877b2fa91d34973</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1551986957?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28264660$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24211170$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kliewer, Erich V</creatorcontrib><creatorcontrib>Mahmud, Salaheddin M</creatorcontrib><creatorcontrib>Demers, Alain A</creatorcontrib><creatorcontrib>Lambert, Pascal</creatorcontrib><title>Human papillomavirus vaccination and Pap testing profile in Manitoba, Canada</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Abstract Background Females who receive the human papillomavirus (HPV) vaccine may believe they are protected from developing cervical cancer and no longer require screening. Concern has also been expressed that vaccinated females are those that would be screened regularly. This study assesses the Pap testing behavior of vaccinated and non-vaccinated females. Methods For this population-based retrospective cohort study, vaccination and screening registries were linked for 3540 vaccinated females aged 15 years and over and 9592 matched non-vaccinated females. Conditional logistic regression, the Kaplan–Meier method and Cox regression were used to examine the association between vaccination and Pap testing. Results Vaccinated females were more likely to have had a Pap test within the year prior to the index date than non-vaccinated females (15–19 years old: OR = 1.38, 95% CI 1.20–1.59; 20+ years old: OR = 2.34, 95% CI 1.98–2.76). In the three-year period after the index date, vaccinated females had a significantly higher cumulative probability of having a Pap test (83.3%) than non-vaccinated females (66.1%). Females who had a Pap test within three years prior to the index date were more likely to have a Pap test after the index date (vaccinated: HR = 5.03, 95% CI 4.65–5.45; non-vaccinated HR = 3.97, 95% CI 3.70–4.24). Being vaccinated had a significant effect on Pap testing (15–19 years old: HR = 1.54, 95% CI 1.39–1.69; 20+ years old: HR = 1.87, 95% CI 1.52–2.31). 80.1% of vaccinated females who had a Pap test prior to the index date also had one subsequent to it, compared to 70.1% for non-vaccinated females. 41.1% of females had not been vaccinated nor had a Pap test. Conclusion The majority of vaccinated females continue to participate in screening, and do so at a higher rate than non-vaccinated females. Renewed efforts need to be made to include the large proportion of non–vaccinated, non–screened females in vaccination and/or screening.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Allergy and Immunology</subject><subject>Alphapapillomavirus - immunology</subject><subject>Applied microbiology</subject><subject>Biological and medical sciences</subject><subject>Cervical cancer</subject><subject>cohort studies</subject><subject>Female</subject><subject>females</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Human papillomavirus</subject><subject>Human papillomavirus (HPV)</subject><subject>Humans</subject><subject>Immunization</subject><subject>Manitoba - epidemiology</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Middle Aged</subject><subject>Miscellaneous</subject><subject>Odds Ratio</subject><subject>Pap test</subject><subject>Papillomaviridae</subject><subject>Papillomavirus Infections - diagnosis</subject><subject>Papillomavirus Infections - epidemiology</subject><subject>Papillomavirus Infections - prevention & control</subject><subject>Papillomavirus Vaccines - immunology</subject><subject>Population Surveillance</subject><subject>probability</subject><subject>Registries</subject><subject>regression analysis</subject><subject>Retrospective Studies</subject><subject>Screening</subject><subject>Tumors</subject><subject>uterine cervical neoplasms</subject><subject>Vaccination</subject><subject>Vaccination - statistics & numerical data</subject><subject>Vaccines</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><subject>Vaginal Smears</subject><subject>Virology</subject><subject>Young Adult</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFktGL1DAQxoMo3nr6J6gFEXywayZp2uRFkUU9YUXhTvAtTNP0yNqmNWkX7r83pasH93JPgeE333yTbwh5DnQLFMp3h-0RjXHebhkFnmpbKtkDsgFZ8ZwJkA_JhrKyyAugv87IkxgPlFLBQT0mZ6xgAFDRDdlfzD36bMTRdd3Q49GFOWarNE5u8Bn6JvuBYzbZODl_nY1haF1nM-ezb-jdNNT4NtuhxwafkkctdtE-O73n5Orzp6vdRb7__uXr7uM-N4KLKa-NKbDlhUELijLOypYJ0zYgbF0yxiRrJDa1FErwRgpeyKqqWYsKGl6oip-TN6tssvJnTrZ076KxXYfeDnPUIKCsBJcV3I8WVSWEkpQm9NUd9DDMwac9kqAAJUslltlipUwYYgy21WNwPYYbDVQvweiDPgWjl2CWcgom9b04qc91b5v_Xf-SSMDrE4DRYNcG9MbFW06mLMty4V6uXIuDxuuQmJ-XaZKgFCrFhUrEh5WwKYKjs0FH46w3tnHBmkk3g7vX7Ps7CqZz3iVbv-2Njbf_oiPTVF8ud7acGXAKhVSS_wUyv8o8</recordid><startdate>20131217</startdate><enddate>20131217</enddate><creator>Kliewer, Erich V</creator><creator>Mahmud, Salaheddin M</creator><creator>Demers, Alain A</creator><creator>Lambert, Pascal</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20131217</creationdate><title>Human papillomavirus vaccination and Pap testing profile in Manitoba, Canada</title><author>Kliewer, Erich V ; Mahmud, Salaheddin M ; Demers, Alain A ; Lambert, Pascal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c535t-bcc4af34cae1902326f25cfd15eb622282d8adb85953d8534877b2fa91d34973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Allergy and Immunology</topic><topic>Alphapapillomavirus - immunology</topic><topic>Applied microbiology</topic><topic>Biological and medical sciences</topic><topic>Cervical cancer</topic><topic>cohort studies</topic><topic>Female</topic><topic>females</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Human papillomavirus</topic><topic>Human papillomavirus (HPV)</topic><topic>Humans</topic><topic>Immunization</topic><topic>Manitoba - epidemiology</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Middle Aged</topic><topic>Miscellaneous</topic><topic>Odds Ratio</topic><topic>Pap test</topic><topic>Papillomaviridae</topic><topic>Papillomavirus Infections - diagnosis</topic><topic>Papillomavirus Infections - epidemiology</topic><topic>Papillomavirus Infections - prevention & control</topic><topic>Papillomavirus Vaccines - immunology</topic><topic>Population Surveillance</topic><topic>probability</topic><topic>Registries</topic><topic>regression analysis</topic><topic>Retrospective Studies</topic><topic>Screening</topic><topic>Tumors</topic><topic>uterine cervical neoplasms</topic><topic>Vaccination</topic><topic>Vaccination - statistics & numerical data</topic><topic>Vaccines</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><topic>Vaginal Smears</topic><topic>Virology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kliewer, Erich V</creatorcontrib><creatorcontrib>Mahmud, Salaheddin M</creatorcontrib><creatorcontrib>Demers, Alain A</creatorcontrib><creatorcontrib>Lambert, Pascal</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kliewer, Erich V</au><au>Mahmud, Salaheddin M</au><au>Demers, Alain A</au><au>Lambert, Pascal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human papillomavirus vaccination and Pap testing profile in Manitoba, Canada</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2013-12-17</date><risdate>2013</risdate><volume>32</volume><issue>1</issue><spage>33</spage><epage>38</epage><pages>33-38</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>Abstract Background Females who receive the human papillomavirus (HPV) vaccine may believe they are protected from developing cervical cancer and no longer require screening. Concern has also been expressed that vaccinated females are those that would be screened regularly. This study assesses the Pap testing behavior of vaccinated and non-vaccinated females. Methods For this population-based retrospective cohort study, vaccination and screening registries were linked for 3540 vaccinated females aged 15 years and over and 9592 matched non-vaccinated females. Conditional logistic regression, the Kaplan–Meier method and Cox regression were used to examine the association between vaccination and Pap testing. Results Vaccinated females were more likely to have had a Pap test within the year prior to the index date than non-vaccinated females (15–19 years old: OR = 1.38, 95% CI 1.20–1.59; 20+ years old: OR = 2.34, 95% CI 1.98–2.76). In the three-year period after the index date, vaccinated females had a significantly higher cumulative probability of having a Pap test (83.3%) than non-vaccinated females (66.1%). Females who had a Pap test within three years prior to the index date were more likely to have a Pap test after the index date (vaccinated: HR = 5.03, 95% CI 4.65–5.45; non-vaccinated HR = 3.97, 95% CI 3.70–4.24). Being vaccinated had a significant effect on Pap testing (15–19 years old: HR = 1.54, 95% CI 1.39–1.69; 20+ years old: HR = 1.87, 95% CI 1.52–2.31). 80.1% of vaccinated females who had a Pap test prior to the index date also had one subsequent to it, compared to 70.1% for non-vaccinated females. 41.1% of females had not been vaccinated nor had a Pap test. Conclusion The majority of vaccinated females continue to participate in screening, and do so at a higher rate than non-vaccinated females. Renewed efforts need to be made to include the large proportion of non–vaccinated, non–screened females in vaccination and/or screening.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>24211170</pmid><doi>10.1016/j.vaccine.2013.10.082</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2013-12, Vol.32 (1), p.33-38 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1516753871 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete; ProQuest Central UK/Ireland |
| subjects | Adolescent Adult Allergy and Immunology Alphapapillomavirus - immunology Applied microbiology Biological and medical sciences Cervical cancer cohort studies Female females Fundamental and applied biological sciences. Psychology Human papillomavirus Human papillomavirus (HPV) Humans Immunization Manitoba - epidemiology Medical research Medical sciences Microbiology Middle Aged Miscellaneous Odds Ratio Pap test Papillomaviridae Papillomavirus Infections - diagnosis Papillomavirus Infections - epidemiology Papillomavirus Infections - prevention & control Papillomavirus Vaccines - immunology Population Surveillance probability Registries regression analysis Retrospective Studies Screening Tumors uterine cervical neoplasms Vaccination Vaccination - statistics & numerical data Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Vaginal Smears Virology Young Adult |
| title | Human papillomavirus vaccination and Pap testing profile in Manitoba, Canada |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T23%3A00%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20papillomavirus%20vaccination%20and%20Pap%20testing%20profile%20in%20Manitoba,%20Canada&rft.jtitle=Vaccine&rft.au=Kliewer,%20Erich%20V&rft.date=2013-12-17&rft.volume=32&rft.issue=1&rft.spage=33&rft.epage=38&rft.pages=33-38&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/j.vaccine.2013.10.082&rft_dat=%3Cproquest_cross%3E3396337651%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1551986957&rft_id=info:pmid/24211170&rft_els_id=S0264410X13014898&rfr_iscdi=true |